Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05074160 · ClinicalTrials.gov registry record
OCS Liver Perfusion (OLP) Post-Approval Registry
A clinical trial of Liver Transplant, sponsored by TransMedics.
- Active
- Registry status
- 166
- Enrollment target
- 9
- Study locations
NCT05074160: Active study of Liver Transplant, sponsored by TransMedics.
NCT05074160 is a study of Liver Transplant that is active but no longer recruiting, run by TransMedics. The registered enrollment target is 166 participants, below the 5,450-participant average among 19 other Liver Transplant trials with a reported enrollment target (97% lower). The trial reports 9 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05074160, a study of Liver Transplant, is active but no longer recruiting, sponsored by TransMedics.
- ACTIVE NOT RECRUITING
- Registry status
- 166 participants
- Enrollment target
- 9
- Study locations
Study Summary
The objective of the OLP Registry is to collect more data on the post-transplant clinical outcomes of DBD and DCD donor livers preserved and assessed on OCS Liver System according to the approved indication and the OCS device performance in the real-world setting.
Primary Outcome
1-year patient survival with the originally transplanted liver (patient and graft survival) post-Liver transplant.
Conditions Studied
Interventions
- DEVICE OCS Liver
Study Locations (9)
California
- University of California San Diego - La Jolla
- University of California San Francisco - San Francisco
Alabama
- University of Alabama - Birmingham
Georgia
- Emory - Atlanta
Massachusetts
- Massachusetts General Hospital - Boston
Michigan
- Henry Ford Hospital - Detroit
Nebraska
- University of Nebraska Medical Center - Omaha
North Carolina
- Duke Medical Center - Durham
Texas
- Houston Methodist - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2021-10-14 |
| Est. Completion | 2026-06 |
What the registry record for NCT05074160 still lists
NCT05074160 is an observational study that tracks outcomes without assigning an intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap, below the 5,450-participant average among 19 other Liver Transplant trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Liver Transplant appearing as the primary indexed condition, and to 1 intervention - of which OCS Liver is the first listed.
NCT05074160 lists 9 locations in 8 states (California, Alabama, Georgia).
Frequently Asked Questions
What is clinical trial NCT05074160 about?
NCT05074160 is a clinical study titled "OCS Liver Perfusion (OLP) Post-Approval Registry". The objective of the OLP Registry is to collect more data on the post-transplant clinical outcomes of DBD and DCD donor livers preserved and assessed on OCS Liver System according to the approved indication and the OCS device performance in the real-world setting.
What is the current status of trial NCT05074160?
This trial is currently active not recruiting. The enrollment target is 166 participants. The study started on 2021-10-14. Estimated completion is 2026-06.
What conditions does trial NCT05074160 study?
This clinical trial studies the following conditions: Liver Transplant.
What interventions are being tested in trial NCT05074160?
The interventions under investigation include: OCS Liver (DEVICE).
Who is sponsoring clinical trial NCT05074160?
This trial is sponsored by TransMedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05074160 being conducted?
This trial has 9 study locations across Alabama, California, Georgia, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05074160's enrollment target sits among peer trials
166 9th of 19 higher than 11 of 19 other Liver Transplant trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Liver Transplant trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
RECRUITING · Phase 2
-
US National OCS Liver Perfusion (OLP) Registry
RECRUITING
-
Liver Transplant CGM
RECRUITING
-
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
RECRUITING · NA
-
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
RECRUITING · Phase 2
-
EVR and EPO for Liver Transplant Tolerance
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI